STOCK TITAN
  1. Home
  2. SEC Filings
  3. NTRA
  4. [Form 4] Natera, Inc. Insider Trading Activity

Natera chair sells 102K shares in preset plan

Natera’s executive chairman reported Rule 10b5-1 plan sales totaling 102,000 shares over two days in mid-September 2026.

Available on EDGAR Accepted by SEC EDGAR
Filing Impact
(Neutral)
Filing Sentiment

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment worksHow the balance works

Form Type
4

Rhea-AI Filing Summary

Natera, Inc. (NTRA) reported that Executive Chairman Matthew Rabinowitz disclosed open-market sales of a total of 102,000 sharesweighted average prices$327.50 to $351.272,000 sharespre-established Rule 10b5-1 trading plans

Insider Rabinowitz Matthew
Role EXECUTIVE CHAIRMAN
Sold 102,000 shs ($34.80M)
Type Security Shares Price Value
Sale Common Stock F1, F17 1,481 $339.2351 $502K
Sale Common Stock F1, F18 2,549 $340.2485 $867K
Sale Common Stock F1, F19 1,813 $341.4067 $619K
Sale Common Stock F1, F20 1,956 $342.1804 $669K
Sale Common Stock F1, F21 2,240 $343.5638 $770K
Sale Common Stock F1, F22 5,839 $344.4859 $2.01M
Sale Common Stock F1, F23 2,700 $345.3798 $933K
Sale Common Stock F1, F24 1,122 $346.6751 $389K
Sale Common Stock F1, F25 2,700 $347.8127 $939K
Sale Common Stock F1, F26 8,094 $348.6465 $2.82M
Sale Common Stock F1, F27 4,206 $349.5097 $1.47M
Sale Common Stock F1, F28 14,500 $350.8069 $5.09M
Sale Common Stock F1, F29 800 $351.245 $281K
Sale Common Stock F30, F31 2,000 $350.0072 $700K
Sale Common Stock F1, F2 1,537 $328.0942 $504K
Sale Common Stock F1, F3 6,015 $329.1171 $1.98M
Sale Common Stock F1, F4 6,206 $330.0514 $2.05M
Sale Common Stock F1, F5 3,494 $330.9752 $1.16M
Sale Common Stock F1, F6 1,000 $332.0169 $332K
Sale Common Stock F1, F7 2,246 $333.0656 $748K
Sale Common Stock F1, F8 2,818 $334.2362 $942K
Sale Common Stock F1, F9 3,754 $335.1805 $1.26M
Sale Common Stock F1, F10 8,459 $336.266 $2.84M
Sale Common Stock F1, F11 2,207 $337.169 $744K
Sale Common Stock F1, F12 1,400 $338.296 $474K
Sale Common Stock F1, F13 2,100 $339.3681 $713K
Sale Common Stock F1, F14 2,000 $340.313 $681K
Sale Common Stock F1, F15 2,700 $341.3467 $922K
Sale Common Stock F1, F16 4,064 $342.5067 $1.39M
Holdings After Transaction: Common Stock — 2,125,394 shares (Direct); Common Stock — 0 shares (Indirect, By spouse)
Footnotes (31)
  1. F1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026.
  2. F2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $327.50 to $328.46 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $328.53 to $329.51 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $329.54 to $330.52 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $330.55 to $331.45 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. F6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $331.58 to $332.52 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. F7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $332.60 to $333.57 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. F8. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $333.71 to $334.69 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  9. F9. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $334.75 to $335.74 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  10. F10. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.75 to $336.74 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  11. F11. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $336.75 to $337.71 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  12. F12. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $337.76 to $338.75 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  13. F13. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $338.80 to $339.74 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  14. F14. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $339.87 to $340.72 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  15. F15. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $340.88 to $341.83 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  16. F16. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $342.03 to $342.76 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  17. F17. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $338.82 to $339.75 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  18. F18. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $339.82 to $340.78 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  19. F19. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $340.89 to $341.87 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  20. F20. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $341.95 to $342.91 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  21. F21. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $343.00 to $343.97 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  22. F22. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $344.00 to $344.99 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  23. F23. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $345.00 to $345.96 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  24. F24. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $346.10 to $347.07 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  25. F25. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $347.12 to $348.09 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  26. F26. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $348.12 to $349.11 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  27. F27. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $349.15 to $350.14 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  28. F28. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.20 to $351.19 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  29. F29. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.20 to $351.27 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  30. F30. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025.
  31. F31. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.07 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Common shares sold 102,000 shares Total common stock sold by Matthew Rabinowitz reported in the Form 4 transaction summary
Number of sale transactions 29 transactions Count of reported sale transactions across September 14–15, 2026
Price range of underlying trades $327.50–$351.27 per share Lowest and highest per-share prices across the multiple transaction ranges described in the footnotes
Representative weighted average sale price $350.8069 per share Weighted average price for a 14,500-share sale of common stock on September 15, 2026
Indirect shares sold by spouse 2,000 shares Common stock held indirectly through spouse sold at a weighted average price of $350.0072 per share
Indirect holdings after spouse sale 0 shares Common stock reported as held indirectly through spouse following the 2,000-share sale
Adoption date of one Rule 10b5-1 plan December 5, 2025 Date a trading plan covering the spouse’s sale was adopted
Adoption date of another Rule 10b5-1 plan June 12, 2026 Date a trading plan covering the reporting person’s sales was adopted
Rule 10b5-1 trading plan regulatory
"The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The reported price in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
indirectly through spouse financial
"These shares were held indirectly through the reporting person’s spouse, as described in the ownership footnote."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Natera (NTRA) disclose for Matthew Rabinowitz?
Natera disclosed that Executive Chairman Matthew Rabinowitz reported selling 102,000 sharesSeptember 14–15, 2026, according to a Form 4 filing.

How many NTRA shares did Matthew Rabinowitz sell and over what period?
Matthew Rabinowitz reported selling 102,000 shares29 separate transactionsSeptember 14 and 15, 2026, as detailed in the Form 4 transaction summary.

At what prices were the NTRA shares sold in Matthew Rabinowitz’s Form 4?
The reported sale prices are weighted averages, with the underlying trades executed in ranges between $327.50 and $351.27 per share, based on footnotes describing the individual price intervals for the multiple transactions.

Were Matthew Rabinowitz’s NTRA share sales under a Rule 10b5-1 plan?
Yes. The filing states that the sales were effected under Rule 10b5-1 trading plans, including a plan adopted on December 5, 2025 and another adopted on June 12, 2026, which pre-arranged the sales.

Did the Form 4 for NTRA include sales of shares held by Matthew Rabinowitz’s spouse?
Yes. One reported transaction covers 2,000 shares of common stock held indirectly through his spouse, sold at a weighted average price of $350.0072 per share, after which no shares were reported as held in that indirect account.

Did Matthew Rabinowitz exercise any options or derivatives in this NTRA Form 4?
No. The filing lists only non-derivative common stock sales and shows no derivative exercises or derivative positions in the derivative transaction and position summaries.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rabinowitz Matthew
(Last)(First)(Middle)
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
(Street)
AUSTIN TEXAS 78753
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
EXECUTIVE CHAIRMAN
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/14/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/14/2026S1,537(1)D$328.0942(2)2,223,857D
Common Stock09/14/2026S6,015(1)D$329.1171(3)2,217,842D
Common Stock09/14/2026S6,206(1)D$330.0514(4)2,211,636D
Common Stock09/14/2026S3,494(1)D$330.9752(5)2,208,142D
Common Stock09/14/2026S1,000(1)D$332.0169(6)2,207,142D
Common Stock09/14/2026S2,246(1)D$333.0656(7)2,204,896D
Common Stock09/14/2026S2,818(1)D$334.2362(8)2,202,078D
Common Stock09/14/2026S3,754(1)D$335.1805(9)2,198,324D
Common Stock09/14/2026S8,459(1)D$336.266(10)2,189,865D
Common Stock09/14/2026S2,207(1)D$337.169(11)2,187,658D
Common Stock09/14/2026S1,400(1)D$338.296(12)2,186,258D
Common Stock09/14/2026S2,100(1)D$339.3681(13)2,184,158D
Common Stock09/14/2026S2,000(1)D$340.313(14)2,182,158D
Common Stock09/14/2026S2,700(1)D$341.3467(15)2,179,458D
Common Stock09/14/2026S4,064(1)D$342.5067(16)2,175,394D
Common Stock09/15/2026S1,481(1)D$339.2351(17)2,173,913D
Common Stock09/15/2026S2,549(1)D$340.2485(18)2,171,364D
Common Stock09/15/2026S1,813(1)D$341.4067(19)2,169,551D
Common Stock09/15/2026S1,956(1)D$342.1804(20)2,167,595D
Common Stock09/15/2026S2,240(1)D$343.5638(21)2,165,355D
Common Stock09/15/2026S5,839(1)D$344.4859(22)2,159,516D
Common Stock09/15/2026S2,700(1)D$345.3798(23)2,156,816D
Common Stock09/15/2026S1,122(1)D$346.6751(24)2,155,694D
Common Stock09/15/2026S2,700(1)D$347.8127(25)2,152,994D
Common Stock09/15/2026S8,094(1)D$348.6465(26)2,144,900D
Common Stock09/15/2026S4,206(1)D$349.5097(27)2,140,694D
Common Stock09/15/2026S14,500(1)D$350.8069(28)2,126,194D
Common Stock09/15/2026S800(1)D$351.245(29)2,125,394D
Common Stock09/15/2026S2,000(30)D$350.0072(31)0IBy spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026.
2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $327.50 to $328.46 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $328.53 to $329.51 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $329.54 to $330.52 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $330.55 to $331.45 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $331.58 to $332.52 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
7. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $332.60 to $333.57 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
8. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $333.71 to $334.69 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
9. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $334.75 to $335.74 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
10. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.75 to $336.74 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
11. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $336.75 to $337.71 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
12. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $337.76 to $338.75 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
13. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $338.80 to $339.74 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
14. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $339.87 to $340.72 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
15. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $340.88 to $341.83 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
16. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $342.03 to $342.76 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
17. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $338.82 to $339.75 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
18. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $339.82 to $340.78 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
19. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $340.89 to $341.87 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
20. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $341.95 to $342.91 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
21. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $343.00 to $343.97 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
22. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $344.00 to $344.99 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
23. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $345.00 to $345.96 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
24. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $346.10 to $347.07 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
25. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $347.12 to $348.09 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
26. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $348.12 to $349.11 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
27. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $349.15 to $350.14 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
28. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.20 to $351.19 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
29. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $351.20 to $351.27 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
30. The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 5, 2025.
31. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.00 to $350.07 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Tami Chen, Attorney-in-Fact09/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

Keep reading

More on NTRA

All NTRA news

Trending in the feed

CNSY
Cerenome Secures National In-Network Agreement with Aetna for CNSide® Open the live feed